ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Aarhus University Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Aarhus University Hospital takes part in 15 sessions at ESMO 2026 in Madrid. Its program centres on blood-based tumour DNA testing and treatment response, especially in colorectal and breast cancers. Topics include detecting residual colorectal cancer after surgery and tracking DNA changes during treatment.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Public university hospital of the Central Denmark Region in Aarhus, Denmark, affiliated with Aarhus University.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Novel error-corrected tumor-informed whole-genome sequencing ctDNA analysis improves postoperative MRD detection in stage II–III colorectal cancer
Friday Poster Display session 2
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Prognostic value of ctDNA-based molecular residual disease using tumor-informed whole-genome sequencing in ACT-naïve stage II-III colorectal cancer
Friday Poster Display session 2
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Prospective evaluation of early ctDNA response by ctDNA-RECIST during palliative systemic therapy across tumor types
Friday Poster Display session 2
Biomarkers & precision oncology
Talk
Sat Oct 24
10:35–10:50
Local treatment: Radiotherapy
Multidisciplinary insights for effective care in gynaecological sarcomas
Sarcoma, CNS, head & neck and rare cancers
Poster
Sat Oct 24
12:00–12:45
Talk
Sun Oct 25
08:30–08:55
Understanding the technology behind ctDNA: Pros, Cons and indications of the different testing platforms
ctDNA in colorectal cancer: State-of-the-art and evolving clinical applications
Gastrointestinal cancers
Poster
Sun Oct 25
12:00–12:45
Clinical validity of the ctDNA response evaluation criteria (ctDNA-RECIST) in patients with advanced biliary tract cancer
Sunday Poster Display session 2
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45
Plasma HPV circulating tumor DNA as minimal recidual disease in anal cancer: Mature outcomes from test and validation cohorts
Sunday Poster Display session 5
Gastrointestinal cancersBiomarkers & precision oncology
Abstract
Sun Oct 25
15:25–15:35
3439O - Impact of removal of immune-related organs on cancer risk
Proffered paper: Prevention, early detection and intervention
Talk
Sun Oct 25
16:45–17:00
How to determine response and treatment choice (incl ctDNA)
Peri-operative management of urothelial cancer
Genitourinary cancers
Poster
Mon Oct 26
12:00–12:45
Poster
Mon Oct 26
12:00–12:45
Trophoblast cell surface antigen 2 (TROP2) protein expression in subtypes of non-small cell lung cancer (NSCLC)
Monday Poster Display session 5
Lung & thoracic cancersBiomarkers & precision oncology
Talk
Mon Oct 26
14:45–15:05
Management of obesity in cancer patients
Balancing weight issues in cancer patients: Not too much and not too little
Nursing & supportive care
Chair
Mon Oct 26
14:45–16:15
Proffered paper 2: Basic science and translation research
with Netherlands Cancer Institute
Biomarkers & precision oncology
Talk
Tue Oct 27
11:00–11:20
Basic science and translational research
Scientific Congress Highlights 1

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Aarhus University Hospital

Tell us what you sell and we’ll find the people at Aarhus University Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction